The Global Sialorrhea Treatment Market is estimated to be valued at US$ 771 million in 2025 and is expected to exhibit a CAGR of 5.3% over the forecast period 2024 To 2031. Sialorrhea, commonly known as drooling or excessive salivation, is a common symptom in many neurological and muscular disorders. It happens when the muscles that control swallowing are weakened or paralyzed due to medical conditions like Parkinson’s disease, Amyotrophic lateral sclerosis (ALS), cerebral palsy, and stroke. Sialorrhea treatment options aim to reduce excess saliva production or enhance the swallowing process. Botulinum toxin type A injection has emerged as the most effective first-line treatment option. Other pharmacological treatment options include anticholinergic medications such as glycopyrrolate and benzodiazepines. Radiotherapy and surgery are also considered in severe cases.
The sialorrhea treatment market is estimated to be valued at USD 771 Mn in 2024 and is expected to reach USD 1,110 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.30% from 2024 to 2031.
Key Takeaways
Key players operating in the sialorrhea treatment market are Merz Pharmaceuticals, US WorldMeds, NeuroHealing, Proveca, and Eisai (via Sloan Pharma). Merz Pharmaceuticals and US WorldMeds dominate the botulinum toxin type A injections segment with their brands Xeomin and Numbrino respectively. NeuroHealing provides radiotherapy options for sialorrhea through its SialoTech device.
The rising prevalence of neurological and neuromuscular conditions associated with sialorrhea is the major factor driving the market growth. As per estimates, more than 1 million people in the United States suffer from Parkinson’s disease alone. Furthermore, improved awareness regarding available treatment options and higher diagnosis rates are also supporting the increased demand for sialorrhea treatments.
Technological advancements are expected to boost the Global Sialorrhea Treatment Market during the forecast period. Companies are developing improved drug delivery methods and minimally invasive procedures for better efficacy and reduced side effects. SialoTech by NeuroHealing uses cyber knife guided radiation therapy which significantly reduces time taken for the procedure compared to traditional radiotherapy approaches.
Market Trends
Increasing focus on combination therapies: Combination treatment approaches using botulinum toxin injections along with other pharmacological options, radiotherapy or surgery are gaining traction. This provides synergistic effects with enhanced efficacy and longer treatment duration.
Rise in pipeline drugs: Pharmaceutical companies are investing in R&D to develop more effective and long acting drugs for sialorrhea treatment. Some drugs in pipeline include serlopitant, trospium chloride and new line of minimally invasive devices.
Market Opportunities
Emerging markets in Asia Pacific: Countries like China and India have a huge Parkinson’s disease population and awareness is rising regarding newer treatment avenues. This provides significant growth potential for sialorrhea treatment market players in APAC region.
Focus on pediatric population: Sialorrhea commonly occurs in children with neurological conditions like cerebral palsy. Developing pediatric specific formulations and management protocols present a lucrative opportunity area.
Impact Of On The Global Sialorrhea Treatment Market Growth
The global coronavirus pandemic dealt a huge blow to the global sialorrhea treatment market. During the peak of the pandemic in 2020-2021, patient visits for other medical conditions declined sharply as healthcare facilities were overwhelmed attending to COVID-19 cases. This led to fewer new cases of neurological conditions like Parkinson’s disease and Alzheimer’s disease being diagnosed, thereby reducing the demand for sialorrhea treatment drugs. Supply chain disruptions caused by lockdowns also impacted the production and distribution of existing drugs. Countries imposed strict travel restrictions that affected business operations of key market players. The shifting focus on COVID-19 vaccines and therapeutics development during this period also diverted research funding away from other therapeutic areas like sialorrhea.
However, as vaccination rates increased and lockdowns eased in 2022, the sialorrhea treatment market has started recovering. With priority now given to resuming elective medical procedures and routine care, new cases of neurological conditions are being identified again driving the need for sialorrhea drugs. Market players have also adapted their strategies, focusing on expanding online sales channels and remote patient engagement practices to overcome disruptions. While demand is yet to return to pre-pandemic levels, projections indicate market growth will steadily accelerate in the coming years backed by increasing awareness, ageing population demographics and approval of new treatment options.
Geographical Concentration Of Global Sialorrhea Treatment Market
North America accounts for the largest share of the global sialorrhea treatment market in terms of value, estimated at over 40% in 2025. This is due to factors like high per capita healthcare spending, rising prevalence of neurological disorders, wide acceptance of innovative drugs and well-established reimbursement policies in countries like the US. Within the region, the US alone contributes more than 80% of the North American market value.
Europe is the second largest geographical market for sialorrhea treatment globally, driven by universal health coverage in major countries and focus on rare disease treatment. Asia Pacific is projected to experience the fastest market growth through 2031. This can be attributed to rising healthcare expenditures, growing medical tourism Industry and expansion of key players targeting the developing markets in China and India with their affordable drug offerings.
Get More Insights On- Global Sialorrhea Treatment Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
Plastic Surgery Clinic